Warning: The NCBI web site requires JavaScript to function. more...
Erythropoietin in the critically ill - is it more than just blood?
Corwin HL.
Crit Care. 2004 Oct;8(5):325-6. Epub 2004 Sep 6.
Related citations
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?
Coleman T, Brines M.
Crit Care. 2004 Oct;8(5):337-41. Epub 2004 Jun 16. Review.
The role of erythropoietin therapy in the critically ill.
Transfus Med Rev. 2006 Jan;20(1):27-33. Review.
Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy.
Park J, Gage BF, Vijayan A.
Am J Kidney Dis. 2005 Nov;46(5):791-8.
Erythropoietin in the critically ill: what is the evidence?
Corwin HL, Eckardt KU.
Nephrol Dial Transplant. 2005 Dec;20(12):2605-8. Epub 2005 Oct 12. Review. No abstract available.
Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury.
Bernhardt WM, Eckardt KU.
Curr Opin Crit Care. 2008 Dec;14(6):621-6. Review.
Recombinant human erythropoietin use in a critically ill Jehovah's witness after cardiac surgery.
Price S, Pepper JR, Jaggar SI.
Anesth Analg. 2005 Aug;101(2):325-7, table of contents.
Anemia and red blood cell transfusion in the critically ill.
Semin Dial. 2006 Nov-Dec;19(6):513-6. Review.
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.
Anaemia in the critically ill patient: monitoring of erythropoietin therapy.
Thomas C, Wiesner C, Melchior SW, Thüroff JW.
BJU Int. 2006 Jun;97(6):1161-4. Review. No abstract available.
Erythropoietin and transfusions among critically ill patients.
Abbott KC.
JAMA. 2003 Mar 26;289(12):1511-2; author reply 1512. No abstract available.
Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR.
Crit Care Med. 2006 May;34(5 Suppl):S160-9. Review.
Bench-to-bedside review: iron metabolism in critically ill patients.
Darveau M, Denault AY, Blais N, Notebaert E.
Crit Care. 2004 Oct;8(5):356-62. Epub 2004 May 13. Review.
Can erythropoietin eradicate red cell transfusions in the critically ill?
Hébert PC, Fergusson DA.
Crit Care Med. 2006 Sep;34(9):2490-1. No abstract available.
Response to the randomized trial of recombinant human erythropoietin in critically ill patients.
Belova E, Kanna B.
Crit Care Med. 2007 Jun;35(6):1632. No abstract available.
Bagshaw SM, Ghali WA.
JAMA. 2003 Mar 26;289(12):1511; author reply 1512. No abstract available.
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
Brines M, Cerami A.
J Intern Med. 2008 Nov;264(5):405-32. Review.
Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.
DeAngelo AJ, Bell DG, Quinn MW, Long DE, Ouellette DR.
Crit Care. 2005 Jun;9(3):R172-6. Epub 2005 Feb 25.
Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
Crit Care Med. 2006 Sep;34(9):2310-6.
Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
Ball AM, Winstead PS.
Pharmacotherapy. 2008 Nov;28(11):1383-90. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on